Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...
Vous n'êtes pas connecté
Gastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal carcinomas, represent a significant global health burden due to their high incidence and mortality rates.
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality...
Unaddressed inequities is the main issue leading to unchanged mortality rates for babies and mothers.
Unaddressed inequities is the main issue leading to unchanged mortality rates for babies and mothers.
Microrobot-packed pill displays remarkable efficacy in combating inflammatory bowel disease in mice, heralding a new frontier in gastrointestinal...
Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer, also known as...
Patients with treatment-refractory cancers who received eligibility and testing waivers to participate in a large basket/umbrella oncology trial had...
The Federal Government has approved the exemption of small businesses, manufacturers, and farmers from paying withholding tax as part of efforts to...
A paper published in May in the American Gastroenterological Association journalCellular and Molecular Gastroenterology and Hepatology focusses on...
Stroke remains one of the leading causes of disability and death worldwide, but recent advances in medical science have brought new hope in treating...